mRNA Therapeutics - Sarfaraz K. Niazi

mRNA Therapeutics

Fast-to-Market Strategies
Buch | Softcover
304 Seiten
2024
CRC Press (Verlag)
978-1-032-16348-2 (ISBN)
58,60 inkl. MwSt
The paradigm shift during the pandemic now allows us to develop new biologics that were never possible before and find treatments for autoimmune disorders that remain untreatable.
This book is the most comprehensive and complete treatise on nucleic acid therapeutic
products, including mRNA vaccines, their manufacturing, formulations, and
testing for safety and efficacy. Details include cGMP-compliant manufacturing and
regulatory filing steps. A new concept of “biosimilar” mRNA vaccine is presented
to secure fast approval of copies of mRNA vaccines. Projections of financial plans
to establish RNA manufacturing facilities are provided, along with details of supply
chain management. Finally, the future of nucleic acid products in gene therapy and
other newer applications is presented, along with a perspective that all new vaccines
will be the nucleic acid type that will further provide first-time prevention of autoimmune
disorders. It is projected that both big pharma and start-ups will enter this field,
and we can expect significant additions to our drug armamentarium soon.

Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and the University of Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field of bioprocessing, drug discovery, drug formulations, thermodynamic systems, alcohol aging, nutraceuticals, and treatment of autoimmune diseases. He has hands-on experience establishing biotechnology projects, from concept to market, including FDA approvals. In addition, he has first-hand experience in establishing RNA therapeutic product development and manufacturing, including the mRNA vaccine for COVID-19. He also serves as an advisor to major pharmaceutical and biopharmaceutical companies, regulatory agencies, and many heads of state. He is also a patent law practitioner. Email: niazi@niazi.com

Background. 1. The Genome Machine. 2. Understanding Nucleic Acids. 3. RNA Therapeutics. 4. Nucleoside Vaccines. 5. cGMP mRNA Vaccine Manufacturing. 6. Regulatory Guidance. Appendix 1. Covid-19 mRNA Vaccine Manufacturing Feasibility. Appendix 2. Pharmacopeial Testing. Appendix 3. Suggested Readings

Erscheinungsdatum
Zusatzinfo 44 Tables, black and white; 15 Line drawings, color; 2 Line drawings, black and white; 55 Halftones, color; 1 Halftones, black and white; 73 Illustrations, black and white
Verlagsort London
Sprache englisch
Maße 156 x 234 mm
Gewicht 453 g
Themenwelt Medizin / Pharmazie Pflege
Medizin / Pharmazie Pharmazie PTA / PKA
ISBN-10 1-032-16348-8 / 1032163488
ISBN-13 978-1-032-16348-2 / 9781032163482
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Annina Bergner; Kirsten Seidel

Buch | Softcover (2024)
Deutscher Apotheker Verlag
39,80
2. Ausbildungsjahr

von Jutta Heller; Isabel Ehrbeck-Lahrs; Astrid Unthan

Buch | Softcover (2021)
Deutscher Apotheker Verlag
20,00